While insulin delivery technology continues to progress, its adoption in the clinic lags behind, particularly in people with type 2 diabetes. In this article the authors present their clinical perspective regarding insulin pen therapy in this population.
No takes yet. Share an insight, caveat, or question.
Bailey et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: